Evidence map›Paper›PMID 41270099›Full record

ArticlePLoS pathogens2025

Reprogramming of lipid metabolism by ORF3a-induced microlipophagy enhances biogenesis of SARS-CoV-2 replication organelle.

Zhifei Li, Xianfeng Hui, Miaomiao Zheng, Zhicheng He, Wenjing Huai, Binbin Ding, Meilin Jin, Yali Qin, Mingzhou Chen

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhifei LiSchool of Life Sciences, Hubei University, Wuhan, China.
Xianfeng HuiState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China.
Miaomiao ZhengState Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, LuoJia Hill, Wuhan, China.
Zhicheng HeState Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, LuoJia Hill, Wuhan, China.
Wenjing HuaiState Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, LuoJia Hill, Wuhan, China.
Binbin DingGuangzhou Laboratory, Guangzhou, China.
Meilin JinState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China.
Yali QinSchool of Life Sciences, Hubei University, Wuhan, China.
Mingzhou ChenSchool of Life Sciences, Hubei University, Wuhan, China.ORCID 0000-0001-5308-6897

Funding

Guangzhou National LaboratoryHubei Provincial Key R&D ProgramNational Natural Science Foundation of ChinaNatural Science Foundation of Wuhan
6 · The paper itself

Abstract

Infection by positive-strand RNA viruses necessitates membrane expansion and elevated phospholipid biosynthesis, whereby fatty acids stored as triacylglycerols in lipid droplets (LDs) are mobilized to promote metabolic processes and membrane biogenesis. The replication organelles (ROs) of coronavirus associate with modified host endomembrane; however, the molecular mechanisms underlying the expansion and modification of these membranes remain poorly understood. Here, we show that viral protein orf3a collaborates with nsp3, nsp4, nsp6 to facilitate the formation of ROs in SARS-CoV-2. Importantly, orf3a targets LDs to ROs, establishing novel membrane contact sites and induces host cell microlipophagy, which supplies essential lipids for RO biogenesis. Subsequently, Following the formation of ROs, nsp3, with assistance from nsp12, indirectly recruits phosphatidylinositol 4-kinase beta (PI4KB) to ROs, to produce phosphatidylinositol 4-phosphate (PI4P). This action creates a PI4P-enriched microenvironment that enhances SARS-CoV-2 replication. Our findings elucidate the mechanism governing RO generation during SARS-CoV-2 infection and suggest that targeting microlipophagy pharmacologically may represent a promising strategy for the development of anti-coronaviruses therapies.

Indexed as

AutophagyCOVID-19Lipid DropletsLipid MetabolismSARS-CoV-2Viroporin ProteinsVirus Replication1-Phosphatidylinositol 4-KinaseAnimalsHumansPhosphatidylinositol PhosphatesViral Nonstructural Proteins1-Phosphatidylinositol 4-KinaseORF3a protein, SARS-CoV-2phosphatidylinositol 4-phosphatePhosphatidylinositol PhosphatesViral Nonstructural ProteinsViroporin Proteins

Identifiers

PMID41270099
PMCPMC12671888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.